This page shows the latest Isis Pharmacueticals news and features for those working in and with pharma, biotech and healthcare.
Will develop antisense drugs for Huntington's disease. Roche is to partner with Isis Pharmaceuticals to research medicines for the Huntington's disease – a rare, genetic brain disorder for which there ... The CHDI Foundation will receive $1.5m as part
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...